摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-6-((4R,5R)-5-heptyl-2,2-dimethyl-1,3-dioxolan-4-yl)-1-phenylhexa-2,4-diyn-1-ol

中文名称
——
中文别名
——
英文名称
(R)-6-((4R,5R)-5-heptyl-2,2-dimethyl-1,3-dioxolan-4-yl)-1-phenylhexa-2,4-diyn-1-ol
英文别名
(1R)-6-[(4R,5R)-5-heptyl-2,2-dimethyl-1,3-dioxolan-4-yl]-1-phenylhexa-2,4-diyn-1-ol
(R)-6-((4R,5R)-5-heptyl-2,2-dimethyl-1,3-dioxolan-4-yl)-1-phenylhexa-2,4-diyn-1-ol化学式
CAS
——
化学式
C24H32O3
mdl
——
分子量
368.516
InChiKey
BJUUJRMVKNFROO-YTFSRNRJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.9
  • 重原子数:
    27
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING TOXICITY AND TREATING OR PREVENTING DISEASES
    申请人:Danishefsky Samuel J.
    公开号:US20110312904A1
    公开(公告)日:2011-12-22
    The present invention provides compounds of Formula (I), compositions comprising an effective amount of a compound of Formula (I), optionally with chemotherapeutic drugs such as a tubulin-binding drug, and methods of their use for reducing the toxicity of cytotoxic agents, treating or preventing cancer or a neuropathic disorder, inducing a chemoprotective phase II enzyme, DNA, or protein synthesis, enhancing the immune system, treating inflammation, improving and enhancing general health or well-being, and methods for making compounds of Formula (I).
    本发明提供了公式(I)的化合物,以及包含公式(I)化合物的有效量的组合物,可选地与化疗药物如微管结合药物一起使用,并用于减少细胞毒性药物的毒性,治疗或预防癌症或神经病理性障碍,诱导化学保护性II期酶、DNA或蛋白质合成,增强免疫系统,治疗炎症,改善和增强整体健康或福祉,以及制备公式(I)化合物的方法。
  • Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
    申请人:Danishefsky Samuel J.
    公开号:US08859615B2
    公开(公告)日:2014-10-14
    The present invention provides compounds of Formula (I), compositions comprising an effective amount of a compound of Formula (I), optionally with chemotherapeutic drugs such as a tubulin-binding drug, and methods of their use for reducing the toxicity of cytotoxic agents, treating or preventing cancer or a neuropathic disorder, inducing a chemoprotective phase II enzyme, DNA, or protein synthesis, enhancing the immune system, treating inflammation, improving and enhancing general health or well-being, and methods for making compounds of Formula (I).
    本发明提供公式(I)化合物,包括含有公式(I)化合物的有效量的组合物,可选地与化疗药物如微管结合药物一起使用,并用于降低细胞毒性药剂的毒性,治疗或预防癌症或神经病理性疾病,诱导化学保护期II酶、DNA或蛋白质的合成,增强免疫系统,治疗炎症,改善和增强一般健康或福祉,并提供公式(I)化合物的制备方法。
  • US8859615B2
    申请人:——
    公开号:US8859615B2
    公开(公告)日:2014-10-14
  • [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING TOXICITY AND TREATING OR PREVENTING DISEASES<br/>[FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS POUR RÉDUIRE LA TOXICITÉ ET POUR TRAITER OU PRÉVENIR DES MALADIES
    申请人:UNIV COLUMBIA
    公开号:WO2010025272A1
    公开(公告)日:2010-03-04
    The present invention provides compounds of Formula (I), compositions comprising an effective amount of a Compound of Formula (I), optionally with chemotherapeutic drug, such as a tubulin-binding drug, and methods of their use for reducing the toxicity of cytotoxic agents, for example chemotherapy agents, treating or preventing cancer or a neurotrophic disorder, inducing a chemoprotective phase II enzyme, DNA, or protein synthesis, enhancing the immune system, treating inflammation, improving and enhancing general health or well-being, and methods for making Compounds of Formula (I).
  • JP5822991
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多